Purchase Order 75N95023P00736

Award Date 9/7/23
Potential Completion Date 9/6/24
Potential Value $120K
Ultimate Awardee
Coherent Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $119,605 firm fixed price purchase order to Coherent NA, Inc. for a Coherent Monaco 1035-40-40 LX series I high-power stimulation laser for cellular manipulation. The laser must deliver at least 40 microjoules per pulse to meet the technical requirements specified in Solicitation Number NIH-NIDA-RFP-23-001 for this research equipment. Coherent Inc. is the parent company of...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), awarded a $360,279.60 firm-fixed-price purchase order to Coherent NA, Inc., a subsidiary of Coherent Inc., for specialized multi-wavelength dual lasers, fixed-wavelength lasers, and related optoelectronic equipment. This is a non-competitive, brand-name acquisition conducted under simplified acquisition procedures without any set-aside restrictions. The equipment will support...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $144,406.50 firm fixed price purchase order to Coherent NA, Inc. for the delivery of a Coherent Chameleon Vision II laser. Per the solicitation, the contract includes delivery of the tunable ultrafast laser to the specified location in Bethesda, Maryland within 70 days, installation, on-site training, and a 12-month warranty period during which the contractor will provide...
This is a purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke to Coherent Inc., a for-profit manufacturer, for two femtosecond laser systems, including installation, training, and a 12-month warranty. The total potential value of the award is $119,380.00. The lasers will be used by the Institute's Spatial Navigation and Memory Unit laboratory to conduct research on synaptic plasticity in...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a Firm Fixed Price purchase order to Coherent Inc., a for-profit manufacturer, for a Chameleon Discovery NX Part 1404200 laser system. The total potential value of the award is $178,360.00, and the completion date is November 30, 2020. No set-aside designation was used. The original federal contract opportunity was a sources sought notice for a broad wavelength range...
This federal contract award is for a purchase order with a value of $178,360.00 issued by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Coherent Inc., a global leader in laser technology. The contract is for the delivery of a high-power, dual-output tunable femtosecond laser system to support multiphoton microscopy, non-linear optics, and ultrafast spectroscopy research at the Unit on Neural Computation and Behavior at the...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) awarded a $217,986.00 firm fixed-price purchase order to Coherent Inc., a global provider of lasers and laser systems, to deliver a tunable laser system. The award supports the NINDS Spatial Navigation and Memory Unit, a new laboratory that will use advanced imaging and behavioral approaches to study the neural basis of spatial navigation and...
Coherent NA, Inc. was awarded a firm fixed-price purchase order valued at sixty-two thousand five hundred ninety-five dollars by the National Institutes of Health's National Institute on Drug Abuse to provide a fixed-wavelength laser. The laser will enhance the stability of the agency's two-photon mesoscope, which is currently sensitive to environmental fluctuations. Under the award, Coherent will deliver one Axon 920-2 TPC fixed-wavelength laser with a center wavelength of 920 nm and a...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $181,361 firm fixed price purchase order to Coherent NA, Inc. to procure a Coherent NA, Inc. Chameleon Discovery NX or equivalent laser with trade-in, including warranty and installation. The solicitation sought replacement of flood damaged equipment and required delivery within 112 days of order receipt. Products and services to be provided under the...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS), to Coherent Inc., a for-profit manufacturer of goods. The contract, which has a ceiling value of $204,297.00, is for the provision of coherent laser group infrared lasers for simultaneous photostimulation and imaging of neural networks in mouse brains in-vivo. The award does not have a set-aside designation, and the...

The National Institutes of Health's National Institute on Drug Abuse awarded a $119,605 firm fixed price purchase order to Coherent NA, Inc. for a Monaco 1035-40-40 LX laser system. This single-wavelength two-photon laser will interface with an existing two-photon microscope at the National Institute of Neurological Disorders and Stroke to add a second light path for precise patterned two-photon optogenetic modulation during in vivo two-photon imaging. The laser is needed to support the Spatial Navigation and Memory Unit's research on the neural basis of spatial navigation and memory in relation to the role of the medial entorhinal cortex in Alzheimer's Disease. Coherent Inc. is the parent company of prime contractor Coherent NA, Inc. The period of performance is one year starting in September 2023.

Generated 12/16/23, 9:02 PM